• 2,3-Dinor-11Beta-Prostaglandin F2 Alpha, Urine
  • Decipher Bladder Cancer Genomic Profiling
  • MDA, Urine
  • Lyme Disease (Borrelia burgdorferi) Antibody, IgG, IgM, Immunoblot
  • Cytochrome P450 2C19 (CYP2C19) Genotyping
  • Serotonin Transporter (SLC6A4) Genotyping
  • Herpesvirus 7 (HHV-7) DNA, Qualitative or Quantitative
  • Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor Resistance, GenoSure
  • Chromosome Analysis, Hematologic Disorders, Blood
  • 11-Deoxycortisol, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /14-3-3 Protein Tau/Theta, Spinal Fluid
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

14-3-3 Protein Tau/Theta, Spinal Fluid
Medical Test

Methodology
Access to 14-3-3 Protein Tau/Theta, Spinal Fluid is restricted.
Loading...